MELBOURNE, Australia , July 29, 2022 /PRNewswire/ -- "Global Medical Cannabis Market" the new research report added in Data Bridge Market Research's reports database. This Research Report spread across 350 Pages, 220 No of Tables, And 60 No of Figures with summarizing top companies, with tables and figures. The rapidly revolutionizing market place demands the best market and business solutions to thrive in the market. This Medical Cannabis report contains comprehensive data of market definition, classifications, applications, engagements, market drivers and market restraints of this industry all of which is derived from Porter's Five Forces analysis. Market definition covered in this Medical Cannabis report gives the scope of particular product with respect to the driving factors and restraints in the market. The sources of data and information mentioned in the Medical Cannabis report are very reliable and include websites, annual reports of the companies, journals, and mergers which are checked and validated by the market experts.
Data Bridge Market Research analyses that the medical cannabis market which was USD 11.0 billion in 2021, would rocket up to USD 54.34 billion by 2029, and is expected to undergo a CAGR of 22.1% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Get Sample PDF Brochure (Including Graphs, Charts & Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-medical-cannabis-market&PNW/29July2022
According to the poll, nearly 13,400 physicians in Canada supplied prescriptions for an average of 2.1 grammes of marijuana each day to patients. The growing number of scientific trials of cannabis-infused medications for various therapeutic areas, particularly the usage of cannabidiol, is boosting market growth. There were around 400 completed or continuing clinical trials as of June 2018 . Clinical trials sponsored by GW Pharmaceuticals totaled 40, whereas clinical trials sponsored by sanofi totaled 38. Furthermore, the narrative among physicians about the benefits and supporting clinical evidence is leading to an increase in patient prescriptions for cannabis-infused medicines.
Medicinal marijuana (MMJ), often known as medical cannabis is marijuana and cannabinoids that doctors recommend for their patients. Due to production and political constraints, the use of cannabis as medicine has not undergone thorough testing. As a result, there has been little clinical study to determine the safety and effectiveness of utilising cannabis to treat ailments.
To provide the intended medical benefits, the dosage of the capsules must be precise before consumption. More dependable are the use of sophisticated machinery, skilled, licensed lab technicians, and the producer. Because medical cannabis is now legal in the United States , the demand for it is skyrocketing, thanks to the medicinal benefits of Cannabis Capsules. As a result, investors are keen on establishing or acquiring plants with appropriate machinery, skilled labor, and a license to produce cannabis capsules. Existing manufacturers are also investing time and skills to innovate for the production of high-quality capsules in appropriate doses.
Some of the major players operating in the medical cannabis market are:
Floyd's of Leadville (U.S.)
Pure Hemp Botanicals (U.S.)
GW Pharmaceuticals PLC (U.K.)
CV sciences Inc. (U.S.)
Access Full 350 Pages PDF Research Report @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-medical-cannabis-market?PNW/29July2022
In March 2021 - STADA Arzneimittel AG, one of Germany's leading pharmaceutical companies, has entered the medical cannabis market with a deal with MediPharm Labs, a Canadian company, to introduce two flower products and six more in the future.
In May 2021 - TCV Sciences, Inc. announced the launch of PLUSCBDTM calm and sleep gummies, two tasty candies that help individuals go back to their normal routines by supporting healthy stress responses and sleep cycles.
The investment made in the study would provide you access to information such as:
Medical cannabis Market [Global – Broken-down into regions]
Regional level split [North America , Europe , Asia Pacific , South America , Middle East & Africa ]
Country wise Market Size Split [of important countries with major market share]
Market Share and Revenue/Sales by leading players
Market Trends – Emerging Technologies/products/start-ups, PESTEL Analysis, SWOT Analysis, Porter's Five Forces, etc.
Market Size by application/industry verticals
Advancements in research and development
Cannabis is now approved for treating various ailments, including restlessness, muscle tightness, persistent discomfort, and the reduction of vomiting and illness caused by chemotherapy. The majority of businesses are making rapid progress in their research into the potential of therapeutic cannabis and hemp.
CBD and THC-modified edibles are becoming increasingly popular throughout all permitted states. In addition, customers and investors are becoming more interested in infused drinks. The convoluted administrative process for cannabis acceptance can act as a roadblock to industry development. The therapeutic properties of cannabis and the ongoing legalisation of cannabis capsules will serve as opportunities for market expansion.
Cannabis makes up a sizable portion of the medical cannabis market. Consumers in the United States provinces where cannabis has been legalised are usually above the age of 50. This demographic profile is predicted to raise cannabis demand in the country due to a higher likelihood of chronic diseases after 50 years of age and the effectiveness of cannabis in treating such conditions. Cannabis's popularity and demand are projected to rise in the future due to ongoing research and standardisation of products for medicinal uses.
To View Detailed Report Analysis, Visit @ https://www.databridgemarketresearch.com/reports/global-medical-cannabis-market?PNW/29July2022
The countries covered in the medical cannabis market report are U.S., Canada and Mexico in North America , Germany , France , U.K., Netherlands , Switzerland , Belgium , Russia , Italy , Spain , Turkey , Rest of Europe in Europe , China , Japan , India , South Korea , Singapore , Malaysia , Australia , Thailand , Indonesia , Philippines , Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia , U.A.E, South Africa , Egypt , Israel , Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil , Argentina and Rest of South America as part of South America .
North America dominates the medical cannabis market due to the growing number of geriatric population along with adoption of innovative medical technology.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the rising health awareness among the people and growing demand of advanced medical technology.
To Check the Complete Table Of Content Click Here @ https://www.databridgemarketresearch.com/toc/?dbmr=global-medical-cannabis-market&PNW/29July2022
Medical Cannabis Extraction Market - Industry Share, Trends and Revenue Growth Forecast https://www.databridgemarketresearch.com/reports/global-medical-cannabis-extraction-market
Medical Cannabis Based Oil Extract-Infused Products Market - Industry Share, Trends and Revenue Growth Forecast https://www.databridgemarketresearch.com/reports/global-medical-cannabis-based-oil-extract-infused-products-market
Europe Medical cannabis Market - Industry Share, Trends and Revenue Growth Forecast https://www.databridgemarketresearch.com/reports/europe-medical-cannabis-market
North America Medical Cannabis Market - Industry Share, Trends and Revenue Growth Forecast https://www.databridgemarketresearch.com/reports/north-america-medical-cannabis-market
Asia-Pacific Medical Cannabis Market - Industry Share, Trends and Revenue Growth Forecast https://www.databridgemarketresearch.com/reports/asia-pacific-medical-cannabis-market
Middle East and Africa Medical Cannabis Market - Industry Share, Trends and Revenue Growth Forecast https://www.databridgemarketresearch.com/reports/middle-east-and-africa-medical-cannabis-market
Cannabis Market - Industry Share, Trends and Revenue Growth Forecast https://www.databridgemarketresearch.com/reports/global-cannabis-market
Europe Cannabis Market - Industry Share, Trends and Revenue Growth Forecast https://www.databridgemarketresearch.com/reports/europe-cannabis-market
North America Cannabis Market - Industry Share, Trends and Revenue Growth Forecast https://www.databridgemarketresearch.com/reports/north-america-cannabis-market
Cannabis Capsule Market - Industry Share, Trends and Revenue Growth Forecast https://www.databridgemarketresearch.com/reports/global-cannabis-capsule-market
Cannabis Seeds Market - Industry Share, Trends and Revenue Growth Forecast https://www.databridgemarketresearch.com/reports/global-cannabis-seeds-market
U.S. Cannabis Seeds Market - Industry Share, Trends and Revenue Growth Forecast https://www.databridgemarketresearch.com/reports/us-cannabis-seeds-market
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune .
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us: Data Bridge Market Research US: +1 888 387 2818 UK: +44 208 089 1725 Hong Kong : +852 8192 7475 Email:- corporatesales@databridgemarketresearch.com
Logo: https://mma.prnewswire.com/media/1011053/Data_Bridge_Market_Research_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/medical-cannabis-market-set-to-reach-usd-54-34-billion-and-is-expected-to-undergo-a-cagr-of-22-1-by-2029--industry-shares-key-players-size-and-future-growth-analysis-301595984.html
SOURCE Data Bridge Market Research
(Bloomberg) -- As health authorities all over the globe search for ways to stop the monkeypox outbreak, investors are snapping up shares of companies that could benefit from the race to quell the disease. Most Read from BloombergThe Crypto Collapse Has Flooded the Market With Rolex and PatekElon Musk’s Antics Turn Owners and Would-Be Buyers Against TeslaTrump Can’t Be Blamed by Militia Group at Jan. 6 Trial, US SaysShock July Stock Rally Was a Monster the Fed May Regret SeeingShares of vaccine p
Investors are trying to make sense of the markets, in face of conflicting signals. Year-to-date, we’re facing deep losses – but more recently, a sharp rally despite this week’s confirmation that we’re in a recession. Government data released on Thursday showed a 0.9% GDP contraction in Q2, which came on the heels of a 1.6% contraction in Q1. That’s two quarters in a row, the definition of a recession. Jim Cramer, the well-known host of CNBC’s ‘Mad Money’ program, reminds us the ‘conventional wis
Looking to buy the dip? Start here.
SIGA Technologies, maker of the only available monkeypox treatment, is working to ramp up manufacturing for broader global distribution.
The energy sector is composed of companies focused on the exploration, production, and marketing of oil, gas, and renewable resources around the world. Energy sector stocks include upstream companies that primarily engage in the exploration of oil or gas reserves, such as Devon Energy Corp. Downstream companies include Marathon Petroleum Corp., which refines and processes oil and gas products for delivery to consumers. Among the industry’s biggest players are Chevron Corp. and ExxonMobil Corp.
If you still think you can't find winning stocks in the S&P 500, you're not looking hard enough.
Each of these five real estate investment trusts (REITs) currently pays a dividend of greater than 5%. For those willing to accept the risks, that’s a better yield than that of the U. S. Government 10-Year Treasury Note. Each REIT trades on the New York Stock Exchange, so plenty of information on these REITs is available from analysts at respected investment firms. Looking for ways to boost your returns? Check out Benzinga's coverage on Alternative Real Estate Investments: Exclusive Offering For
It is now guiding for third-quarter revenue of $15 billion-$16 billion vs. the $18.67 billion consensus. As for full-year 2022, its EPS expectation is now $2.30, down from its prior forecast of $3.60 and the $3.39 consensus. In terms of revenue for the year, Intel now expects $65 billion-$68 billion, down from $76 billion and well below the $74.4 billion consensus.
This has been a year to remember for investors in seemingly all the wrong ways. Since the major U.S. indexes hit their respective all-time closing highs between mid-November and the first week of January, the timeless Dow Jones Industrial Average, broad-based S&P 500, and growth-driven Nasdaq Composite (NASDAQINDEX: ^IXIC) have shed as much as 19%, 24%, and 34% of their value. You'll note by the drop in the S&P 500 and Nasdaq that both indexes have entered a bear market.
Warren Buffett energy favorite Occidental Petroleum is near a buy point, but earnings are due Tuesday. Check out this week's stocks to watch.
These three intriguing companies may offer potential over the long haul, but could struggle in a recession.
Intel's second-quarter revenue fell 17% compared with its first quarter. Bernstein notes that's the worst sequential June quarter performance for the company going back at least to the year 2000.
Is the bear market over? The S&P 500 gained 9% in July. Bank of America says it's a bear market rally and danger lies ahead for stocks.
(Bloomberg) -- Investors should stay wary of US stocks and bonds as inflation remains a threat and recession looms, according to Rebecca Patterson, chief investment strategist at Bridgewater Associates.Most Read from BloombergThe Crypto Collapse Has Flooded the Market With Rolex and PatekElon Musk’s Antics Turn Owners and Would-Be Buyers Against TeslaTrump Can’t Be Blamed by Militia Group at Jan. 6 Trial, US SaysShock July Stock Rally Was a Monster the Fed May Regret SeeingThe stock market, whic
Ford Motor lifted its quarterly dividend to 15 cents a share, a 50% boost, while Hershey raised its payout by 15%.
Shares of the Illinois-based drugmaker AbbVie (NYSE: ABBV) were down by a hefty 5% as of 2:32 p.m. ET Friday afternoon. As a result, the Dividend Aristocrat's market capitalization has slipped by a staggering $13.2 billion today. Ahead of the opening bell, AbbVie announced its 2022 second-quarter earnings.
For much of the last 10 years, Bitcoin (CRYPTO: BTC) has been driving the conversation when it comes to alternative investments. It’s not hard to understand why. Bitcoin is a perfect storm in terms of its ability to generate press and spur casual and seasoned investors to make huge bets on it. Many investors hailed Bitcoin as the currency of the future and cleared their portfolios to put everything in Bitcoin. They looked like geniuses when Bitcoin hit an all-time high of almost $68,000 in Novem
After reaching an all-time high in March 2022, the price of gold retreated below $1,700 an ounce on July 21 as a strong U.S. dollar outweighs gold's luster. Gold exchange-traded funds (ETFs) provide a means of investing in the yellow stuff without the hassle of physically holding gold coins or bars -- which can be a security risk and often costs a hefty premium above the spot price. Two well-known gold ETFs are the SPDR Gold Shares ETF and the iShares Gold Trust, which have net assets of $61.34 billion and $29.8 billion, respectively.
Image source: The Motley Fool. Vale S.A. (NYSE: VALE)Q2 2022 Earnings CallJul 29, 2022, 10:00 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood morning, ladies and gentlemen.
The company's future is in doubt after losing a key patent litigation